Dennis Wijnker

Chief Tech/Sci/R&D Officer en LIFEMD, INC. .

48 años

Technology Services

Health Services

Perfil

Dennis Wijnker is currently the Chief Technology Officer at LifeMD, Inc. He previously worked at Doctor Evidence LLC as the Senior Vice President-Technology from 2009 to 2021.

Cargos activos de Dennis Wijnker

Empresas	Cargo	Inicio
LIFEMD, INC.	Chief Tech/Sci/R&D Officer	13/12/2021

Todos los cargos activos de Dennis Wijnker

Antiguos cargos conocidos de Dennis Wijnker.

Empresas	Cargo	Fin
Doctor Evidence LLC Doctor Evidence LLC Packaged SoftwareTechnology Services Doctor Evidence LLC is a healthcare technology company that provides a platform for life sciences teams to identify breakthrough insights from published medical literature, drug labels, regulatory documents, and third-party data. The private company is based in Santa Monica, CA and was founded by Robert J. Battista, who has been the CEO since incorporation. The platform enables more informed decision making and faster time-to-market for accelerated impact, making it the preeminent evidence-based insights platform for life sciences.	Chief Tech/Sci/R&D Officer	01/01/2021

Ver el detalle de la experiencia de Dennis Wijnker.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Dennis Wijnker.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
LIFEMD, INC.	Health Services

Empresas privadas	1
Doctor Evidence LLC Doctor Evidence LLC Packaged SoftwareTechnology Services Doctor Evidence LLC is a healthcare technology company that provides a platform for life sciences teams to identify breakthrough insights from published medical literature, drug labels, regulatory documents, and third-party data. The private company is based in Santa Monica, CA and was founded by Robert J. Battista, who has been the CEO since incorporation. The platform enables more informed decision making and faster time-to-market for accelerated impact, making it the preeminent evidence-based insights platform for life sciences.	Technology Services